The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0107234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Percent Free Prostate-Specific Antigen: Entering a New Era in the Detection of Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer

ISRN Oncology
2012English

Pro PSA: A More Cancer Specific Form of Prostate Specific Antigen for the Early Detection of Prostate Cancer.

Keio Journal of Medicine
Medicine
2003English

The Role of Prostate-Specific Antigen in Prostate Cancer Screening

Romanian Review of Laboratory Medicine
2014English

Targeting Free Prostate-Specific Antigen forIn VivoImaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone

Cancer Biotherapy and Radiopharmaceuticals
Nuclear MedicineRadiologyPharmacologyCancer ResearchOncologyImagingMedicine
2012English

The Novel Prostate Cancer Antigen 3 (PCA3) Biomarker

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2010English

Recommendations on Screening for Prostate Cancer With the Prostate-Specific Antigen Test

CMAJ
Medicine
2014English

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen

Frontiers in Oncology
Cancer ResearchOncology
2018English

Prostate-Specific Antigen (PSA) Assay for Early Detection of Prostate Cancer Recurrence

Science-Business eXchange
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy